ADViRNA
Oligonucleotide design, synthesis, and screening for therapeutic pipelines
ADViRNA provides oligonucleotide design, synthesis, and screening services with proprietary chemical modifications and conjugation technologies for therapeutic siRNA and ASO development.
Phases
Services
Modalities
About this organization
ADViRNA offers comprehensive contract research and manufacturing services for therapeutic oligonucleotides, including rational design, high-quality synthesis with chemical modifications, and comprehensive screening to identify effective candidates. The company provides siRNA reagents with self-deliverable RNAi technology for gene knockdown applications. Core capabilities include oligonucleotide conjugations, chemical modifications for enhanced stability and efficacy, and the proprietary HYBRID-ON™ oligonucleotide detection assay.
Related companies
Similar profiles by shared services, phases, and indications.
Sussex Research Laboratories Inc.- CMC Analytical Development
- Bioconjugation Services
Cassia, LLC- Translational Research
- Oligonucleotide
TATAA Biocenter- Translational Research
- Oligonucleotide
AAVATAR Therapeutics- Translational Research
Clutch Biotechnologies, Inc.- Translational Research
Icosagen- CMC Analytical Development
- Bioconjugation Services
Cyagen Biosciences- Translational Research
- Oligonucleotide
Abzena- CMC Analytical Development
- Bioconjugation Services
Submit a verified review for this organization.
Markdown mirror: /companies/advirna.md